These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1826871)

  • 1. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G
    Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T; Gavelli MS; Vitaliano E; Santini G; Catalano A; Rossi FG; Tozzi J; Caridis R; Guarini G
    Clin Ter; 1990 Mar; 132(5):307-13. PubMed ID: 2139833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
    Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M
    Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy.
    Vega GL; Grundy SM
    JAMA; 1990 Dec; 264(21):2759-63. PubMed ID: 2232062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of primary mixed hyperlipidemia with lovastatin.
    Vega GL; Grundy SM
    Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
    Crepaldi G; Baggio G; Arca M; Avellone G; Avogaro P; Bittolo Bon G; Bompiani GD; Capurso A; Cattin L; D'Alŏ G
    Arch Intern Med; 1991 Jan; 151(1):146-52. PubMed ID: 1898694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
    Ros E; Zambón D; Bertomeu A; Cusó E; Sanllehy C; Casals E
    Arch Intern Med; 1991 Feb; 151(2):301-5. PubMed ID: 1992957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
    Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E
    Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA; Spósito AC; Mansur AP; Solimene MC; Chamone D; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
    Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
    Lamendola C; Abbasi F; Chu JW; Hutchinson H; Cain V; Leary E; McLaughlin T; Stein E; Reaven G
    Am J Cardiol; 2005 Jan; 95(2):189-93. PubMed ID: 15642550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.